The life of a diabetic is very heavy because they have to make regular insulin injections, or use a special pump that does it for them. In the near future it will become superfluous, as the Swiss company Novartis has developed a pill-pill that will take over this task.
Pills called Rani were developed in collaboration with Rani Therapeutics, and their role is to provide regular insulin directly to the patient’s body. The pill swallows like a normal tablet, and inside it is a small robot.
The builders of this medical nanorobot ancestor have convinced us that Rani can deliver not only insulin but also many other types of injections that help with diseases such as rheumatoid arthritis, psoriasis, and multiple sclerosis.
Now all they have to do is check if additional functionality is actually possible, so developers plan another series of tests that will last for the next 24 months.